AMPX: Amprius Technologies Stock Price, Analysis & Forecast: 1 Year and 5 Year Targets
Amprius Technologies: 1-Year and 5-Year Forecast Outlook and Rating
Amprius Technologies (AMPX) has an immediate Strong Buy & Keep consensus AI recommendation, based on 11 AI analysts.
The 1-year target is $7.41 for , with +28.42% expected return (+28.42% including net dividends) and a STRONG BUY rating.
The 5-year target is $11.20 for , with +94.11% expected return (+94.11% including net dividends) and a STRONG BUY rating.
Latest available market price: USD 5.77, as of 20 Nov 2026.
Dividend calculation details
Calculated net annual dividend yield: 0%. As of 2026-11-20.
Gross TTM: 0% · Two-year annualized gross: 0%.
Tax withholding assumption: 30% (US). One-off special payments are excluded.
Original published assumption: 0% per year.
Return estimates compound the net annual yield at a constant rate over the stated return horizon (the remaining time to the fixed target date for current returns): (1 + price return) × (1 + net annual yield)years − 1.
Targets retain their original publication dates. Returns use the dated market close and the time remaining to each fixed target date. Current ratings also require fresh quotes and analysis, with more than 90 days remaining. Past targets have no forward return. Eligibility checked .
Amprius Technologies Flagship Insight
The Battery Growth Story Now Hinges on Who Funds the Ramp
High consensus supports expanding drone-battery demand and capital-efficient outsourced production, while sharp divergence centers on cash conversion and shareholder capture. Domestic qualification can unlock defense procurement, but conditional subsidies, supplier dependence, dilution and valuation compression make recurring, grant-excluded cash generation the decisive investment test.
How were the Investment Thesis and Forecasts created?
11 AI advisors, guided by 9 analytical frameworks, contribute to the deep analysis by iPulse AI Engine.
Warren Buffett (Value Purist)
Sherlock Holmes (Whistleblower)
Universal Investor (Polymath)
Ray Dalio (Strategist)
Machiavelli (Insider)
J.P. Morgan (Titan)
Elon Musk (Visionary)
Michael Burry (Vulture)
Superintelligence (Anthropologist)
Ran across these frontier AI models
Google Gemini 4 Hydrogen
OpenAI GPT-6.1 Sol
Anthropic Claude Opus 5.5
Latest published deep-analysis batch. Audit published forecasts in full transparency
Amprius Technologies: Investment Thesis Summary
Dotted terms link to the glossary; hover or focus for a preview. Browse technical terms
If you invest $10,000 in Amprius Technologies at the latest market close (20 Nov 2026): $19,411 by Nov 2031 versus $14,502 for S&P 500 benchmark.
Returns use the same dated market close, fixed targets and remaining dividend period as the forecast table.
Amprius is commercializing a useful endurance advantage, but capital-light production is not yet cash-light growth. Repeat drone orders and partner manufacturing can scale gross profit without another owned gigafactory. The base case is a larger, profitable specialist whose equity appreciation trails enterprise growth because working capital, supplier economics and dilution intercept shareholder value. Starting valuation already capitalizes meaningful success, making grant-excluded cash conversion more important than another energy-density milestone. The strongest counterargument is that the lease-exit payment is nonrecurring and improved collections could accelerate self-funding; however, conditional domestic funding and qualification costs prevent treating that outcome as established.
Key insights
- Domestic sourcing is simultaneously market access and a cost reset; procurement eligibility creates value only when accepted output earns adequate margins after localization.
- A production subsidy lowers capital requirements without validating demand, so milestone receipts can improve liquidity even while recurring customer economics remain unproven.
- Qualification protects specialist pricing, but external suppliers and concentrated buyers share the rents; technological differentiation need not produce proportionate growth in per-share earnings.
Continue reading Amprius Technologies analysis with Base subscription
See Base accessAmprius Technologies: 5 Year Consensus Forecast
20 quarterly price targets, returns and rationale, with advisor range and benchmark
Forward returns are updated using the latest market close price of USD 5.77, as of 20 Nov 2026.
Dividend calculation details
Calculated net annual dividend yield: 0%. As of 2026-11-20.
Gross TTM: 0% · Two-year annualized gross: 0%.
Tax withholding assumption: 30% (US). One-off special payments are excluded.
Original published assumption: 0% per year.
Return estimates compound the net annual yield at a constant rate over the stated return horizon (the remaining time to the fixed target date for current returns): (1 + price return) × (1 + net annual yield)years − 1.
The consensus target follows an expert-weighted price path synthesized from 11 AI advisor opinions. See Opinion weights and rationale for the exact allocation and reasoning.
Forecast methodology and reference values
Published targets are anchored on 13 Nov 2026 at USD 7.93. Original quarter-to-quarter target changes are retained. Forward returns use the remaining time to each fixed target date.
The pessimistic and optimistic advisor base cases are the lowest and highest published advisor base-case targets for each quarter. The advisor at either extreme can change between quarters. Benchmark values are in USD.
Scroll the table horizontally to read every column.
| Quarter | Consensus target (USD) | Forecast quarter-to-quarter price change | Forward price return | Forward return incl. net dividends | Forecast rationale | Pessimistic Advisor Base Case (USD) | Optimistic Advisor Base Case (USD) | S&P 500 benchmark (USD) |
|---|---|---|---|---|---|---|---|---|
| $7.34 | -7.49% | +27.21% | +27.21% | Working-capital demands and government-supported adjusted earnings overshadow shipment momentum. Restrictive discount rates and unresolved offshore sourcing encourage investors to reduce the commercialization premium, while the optimistic case depends on collections improving faster than current disclosures establish. | $7.00 | $8.24 | $736 | |
| $6.83 | -6.83% | +18.37% | +18.37% | Domestic launch spending and supplier deposits keep financing risk ahead of revenue growth. A potential equity raise weighs on existing ownership, although the scale and necessity of issuance remain conditional on receivable collections and accepted funding milestones. | $5.96 | $8.81 | $724 | |
| $7.14 | +4.39% | +23.74% | +23.74% | Repeat UAV orders and initial domestic partner shipments restore delivery credibility after the financing reassessment. Better logistics and partial liquidity stabilization support recovery, while qualification costs and competitive cylindrical pricing prevent a clean improvement across every margin measure. | $5.35 | $8.39 | $722 | |
| $7.41 | +3.83% | +28.42% | +28.42% | Broader shipments begin absorbing commercialization overhead, supporting a further recovery in confidence. Approaching defense sourcing requirements increase the value of qualified supply, but domestic provenance and continuing cash consumption keep investors from treating the regulatory opportunity as secured. | $5.08 | $9.36 | $724 | |
| $7.51 | +1.43% | +30.16% | +30.16% | Domestic market access begins to offset the financing discount, but commissioning and qualification friction limit the advance. The central disagreement is whether initial compliant shipments demonstrate durable economics or merely precede another period of expensive utilization ramping. | $5.47 | $10.67 | $735 | |
| $7.95 | +5.76% | +37.78% | +37.78% | Accepted production milestones and initial qualified domestic deliveries ease funding uncertainty. Improved procurement access supports the recovery, although some scenarios still expect startup inefficiencies, and the production award remains distinct from recurring customer orders or unrestricted cash. | $6.01 | $11.64 | $752 | |
| $8.39 | +5.55% | +45.41% | +45.41% | Higher partner throughput spreads qualification and engineering costs across more cells, strengthening operating leverage. Domestic repeat orders support appreciation, while lower-margin commercial formats and uneven startup yields preserve uncertainty about how much gross profit reaches shareholders. | $6.23 | $11.21 | $754 | |
| $8.74 | +4.16% | +51.47% | +51.47% | More predictable replenishment and better collections narrow the gap between reported improvement and cash generation. The domestic ramp supports further confidence, but positive adjusted earnings alone remain insufficient because government receipts and supplier advances can obscure recurring economics. | $5.98 | $12.29 | $780 | |
| $8.71 | -0.27% | +50.95% | +50.95% | Customer negotiations and intermittent purchasing pauses interrupt the recovery despite continuing defense demand. The stronger evidence favors a valuation pause rather than a demand breakdown, as investors test whether qualified platforms protect pricing when competing cells improve. | $6.15 | $13.04 | $802 | |
| $9.08 | +4.17% | +57.37% | +57.37% | Reorders and a richer aviation mix offset earlier purchasing hesitation, restoring confidence in operating leverage. Improving inventory conversion supports the advance, while commercial pricing competition prevents broader shipment growth from translating automatically into proportionate earnings gains. | $5.85 | $12.29 | $819 | |
| $9.41 | +3.65% | +63.08% | +63.08% | Better partner utilization and demanding aviation applications support continued earnings progress. Rival silicon-rich cells constrain some commercial pricing, so appreciation depends more on retained product mix and conversion efficiency than on an expanding technology premium. | $6.07 | $13.12 | $821 | |
| $9.72 | +3.30% | +68.46% | +68.46% | Recurring profitability becomes more credible as scale absorbs development spending and collections stabilize. The stock increasingly responds to cash-backed operating gains rather than headline capacity, with supplier economics and a larger diluted share base limiting shareholder participation. | $5.90 | $14.16 | $842 | |
| $9.63 | -0.92% | +66.90% | +66.90% | Renewal negotiations and competing high-energy cells expose the limits of premium pricing, prompting renewed valuation discipline. Defense replenishment remains supportive, but investors demand evidence that manufacturing savings stay with the company rather than passing entirely to customers. | $5.66 | $14.87 | $863 | |
| $9.94 | +3.26% | +72.27% | +72.27% | Improved yields, supplier terms and renewed platform demand offset customer concessions, supporting earnings recovery. The advance relies on execution within the existing manufacturing network, not a new speculative growth market, while continuing process investment restrains immediately distributable cash. | $5.82 | $14.45 | $871 | |
| $10.26 | +3.23% | +77.82% | +77.82% | Slower inventory growth and repeat platform purchases improve cash conversion, reinforcing the economic value of outsourced production. Broader end markets provide incremental support, but technology upkeep and procurement lumpiness prevent investors from assuming uniformly stable industrial margins. | $5.71 | $15.15 | $874 | |
| $10.55 | +2.83% | +82.84% | +82.84% | More consistent operating cash generation reduces dependence on fresh equity, improving existing shareholders' participation in growth. Recurring aviation and defense demand supports measured appreciation, although maturing sales growth and conventional hardware economics constrain further valuation expansion. | $5.82 | $16.06 | $896 | |
| $10.40 | -1.43% | +80.24% | +80.24% | Rival product improvements, employee equity issuance and ongoing development spending renew scrutiny of per-share economics. Established programs cushion demand, but a slower growth profile shifts attention from energy-density leadership toward sustainable earnings and cash returns on invested capital. | $5.65 | $16.70 | $912 | |
| $10.73 | +3.17% | +85.96% | +85.96% | Renewed customer programs and improving collections demonstrate that qualification relationships retain commercial value. Earnings delivery supports recovery despite continuing dilution, while the more optimistic case depends on replacement demand becoming increasingly predictable across the installed platform base. | $5.76 | $16.39 | $924 | |
| $10.93 | +1.87% | +89.43% | +89.43% | Improving cash conversion and internally funded research support further measured progress as the specialist franchise matures. Competitive pricing and continuing reinvestment remain constraints, making diluted earnings growth more important than nominal capacity expansion or additional technology announcements. | $5.65 | $17.03 | $939 | |
| $11.20 | +2.44% | +94.11% | +94.11% | The horizon closes with a larger, increasingly cash-generative battery specialist rather than a protected monopoly. Successful commercialization supports further progress, but supplier bargaining, accumulated dilution and a normalized earnings valuation leave shareholders capturing only part of the enterprise's expansion. | $5.76 | $17.55 | $965 |
Show remaining 18 quartersCollapse to first 2 quarters
All 20 quarters are displayed in the table above.
Amprius Technologies Stock Analysis & Scenarios Deep Dive
Amprius Technologies: Alpha Gap & Repricing Catalysts
Market Narrative
What does the market currently expect? Dated analyst estimates cited in the inputs remain optimistic about a defense-battery franchise, while contemporaneous price declines signal financing skepticism. Those are opposing narratives, not evidence of uniform positioning. Valuation implies successful domestic qualification and durable margins; company presentations support growth, but neither measured ownership data nor independently verified positioning establishes a dominant public belief.
Alpha Gap
What is the biggest difference between market expectations and our AI forecasts? The crowd modestly overestimates near-term risk-adjusted value; a compelling five-year mispricing is not established. The best-supported gap is between valuation-implied manufacturing independence and the reality that suppliers, receivables and milestone funding still govern cash availability. That favors caution toward optimistic earnings extrapolation, not dismissal of the technology. The strongest challenge is faster collections after the nonrecurring lease exit, which could let recurring drone orders finance growth sooner than the cautious paths assume.
Repricing Catalyst
What could make the market recognize and close that gap? Grant-excluded operating cash flow during the 2027 domestic ramp is the clearest recognition trigger: it separates profitable shipments from funded expansion. Persistent collection delays or discounted financing would validate the modest overpricing concern; two consecutive positive quarters would challenge it. Accepted production milestones through 2028 and binding procurement awards during 2027–2029 would test whether compliance creates recurring earnings. Cash conversion may still improve too slowly to prevent dilution.
Amprius Technologies: Sentiment and Timing
What do sentiment, volatility, and the market-recognition cycle suggest about the thesis timing?
- Greed and Fear Sentiment
- Mixed
- Volatility Regime
- High Erratic
- Convergence Cycle Position
- Mixed
Volatility expectations align, but cycle interpretations split between a financing-driven reversal and growing recognition of a viable specialist. Optimistic analyst commentary coexists with fearful trading signals, making operating cash evidence more useful than sentiment for timing exposure.
Macro Regime Fit
Does the current market environment support the thesis? The backdrop is mixed: defense autonomy and localization support demand, while restrictive financing conditions penalize distant profits and make any equity raise more costly. The decisive exposure is not consumer electric-vehicle spending but the interval between offshore-dependent shipments and qualified domestic output. Trade restrictions or procurement delays would lengthen that funding gap.
Advisor Disagreement
What do our AI Advisors disagree about most? The central disagreement is whether working-capital absorption is a temporary bridge or a recurring tax on expansion. Optimistic paths remove the one-time lease payment, assume faster collections and expect compliant capacity to protect margins. Cautious paths anticipate dilution, higher domestic costs and valuation migration toward specialty hardware. These are real economic differences. Some apparent disputes instead reflect June versus September trailing periods, equity value versus enterprise value, and grant-supported versus recurring earnings. Collections, accepted production milestones and grant-excluded cash generation would resolve more than another headline energy-density record.
Thesis Change
What changed in the thesis since the previous forecast? Commercialization remains credible, but government-dependent earnings and conditional domestic funding materially weaken the earlier expectation of rapid financial independence. -- The prior thesis expected positive operating income and sustainable cash generation in early 2027. Current reporting shows continued operating cash absorption and government-supported adjusted earnings, moving the decisive proof into the domestic ramp. -- The production award improves prospective capital efficiency, yet most funding remains conditional. Supplier dependence and qualification therefore carry more weight, tempering confidence that revenue growth becomes per-share cash generation.
Amprius Technologies: Critical Influencing Factors
Near-certain positive forcesTop Drivers & Tailwinds
Near-certain forces that support the investment thesis. These forces are treated as part of the base case (at least 75% probability of occurrence, as generation guidance). Impact columns are specific to this asset class.
Scroll to view all columns
| Driver / Tailwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Endurance earns repeat orders | Sector And Industry | +45% | +65% | Mission endurance, rather than commodity battery volume, is the strongest revenue engine. Existing drone shipments and expanding North American adoption demonstrate commercial demand, while repeat platform purchases spread engineering costs across more cells. Qualification supports premium positioning over five years, but advertised maximum energy density is application-dependent and does not establish monopoly pricing. |
| Factories outsourced, leverage retained | Operational Efficiency | +30% | +40% | Outsourcing separates shipment growth from another owned-gigafactory build. The Brighton exit and access to conventional partner lines reduce fixed commitments, allowing greater volume to absorb development and commercial overhead. This capital-efficiency advantage should persist, although nominal capacity is not qualified output and lower physical investment does not eliminate supplier advances or customer credit. |
| Domestic sourcing unlocks market access | Regulatory | +35% | +45% | Domestic sourcing can turn compliance from a restriction into market access. Staged partner qualification and an awarded, milestone-based production agreement support participation in procurement-sensitive defense programs. Even partial execution can improve revenue quality over the horizon; the benefit does not require full funding, but neither statutory deadlines nor installed equipment guarantee accepted cells. |
| Standard tools widen product reach | Innovation And Product | +30% | +40% | Compatibility with conventional lithium-ion equipment makes the SiCore platform commercially scalable beyond its original pilot infrastructure. Selective aviation and other weight-sensitive applications can improve product mix and sustain qualification-led sales. The durable driver is manufacturability plus application engineering, not an assumption that laboratory specifications automatically translate into high-cycle robotics or mass passenger aviation. |
Near-certain negative forcesTop Frictions & Headwinds
Near-certain forces that could slow, cap, or damage the thesis. These forces are treated as part of the base case (at least 75% probability of occurrence, as generation guidance). Impact columns are specific to this asset class.
Scroll to view all columns
| Friction / Headwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Growth meets valuation gravity | Macroeconomic And Macrofinancial | -35% | -0.0% | A premium starting valuation can absorb substantial business improvement before shareholders benefit. As growth moderates and investors shift from sales to recurring earnings, the multiple faces downward pressure, reinforced by restrictive financing conditions. The degree of compression remains disputed; successful qualification can preserve a specialist premium, so automatic convergence to generic hardware valuations is not assumed. |
| Cash growth outpaces collections | Capital Allocation | -28% | -0.0% | Financing inventory, supplier deposits and receivables ahead of collections remains a recurring constraint on expansion. Equity compensation and potential financing reduce each existing share's claim even as the enterprise grows. The lease-exit payment should not be extrapolated as recurring burn, and dilution itself changes ownership rather than mechanically reducing aggregate company earnings. |
| Domestic access carries transition costs | Political And Geopolitical | -25% | -30% | Moving from offshore-dependent supply toward accepted domestic production brings qualification expense, startup inefficiency and provenance checks before utilization benefits arrive. Existing materials relationships also retain tariff and logistics exposure. These transition costs should persist across the ramp, although their magnitude is unresolved and severe delivery interruption belongs in downside tails, not the base case. |
| Suppliers and buyers share rents | Competitive Positioning | -22% | -25% | Qualification creates customer stickiness, not exclusive control of economics. External manufacturers and materials suppliers retain bargaining power, while concentrated buyers can demand volume discounts and qualify rival chemistries. Competition should limit premium retention and require continuing development spending over five years, especially in standardized formats; specialized aviation can retain better pricing than broader mobility. |
Amprius Technologies: What Could Break or Accelerate the Thesis
Event Risk Score: Very High 93/100Asset-level relative pressure from clustered consensus frictions and tail risks. This is not the probability or risk score of an individual force.Plausible downside scenariosTail Risks
Tail yet plausible downside scenarios selected for their highest potential impact.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| Offshore supply bridge breaks | 30% | -55% | An export restriction, supplier dispute or material qualification failure interrupts critical offshore inputs before substitutes are accepted during 2027–2030. Delivery cancellations and expensive requalification could strand advances, impair earnings and force emergency financing. A representative 30% probability reflects disclosed supply dependencies, tempered by Korean and U.S. diversification; relocating final assembly alone does not remove upstream exposure. |
| Domestic ramp loses funding | 30% | -45% | A rejected production milestone or prolonged qualification delay during 2027–2029 could suspend expected grant receipts while inventory and customer balances still require funding. That simultaneous loss of cash and procurement access could force a distressed equity raise. A representative 30% probability reflects staged partner mitigation, but the partly obligated award leaves the funding bridge vulnerable. |
Plausible upside scenariosTail Opportunities
Tail yet plausible upside scenarios selected for their highest potential impact.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| Anchor drone program award | 35% | +80% | A named U.S. or allied drone program awards a binding multiyear, minimum-volume supply contract during 2027–2029, following domestic acceptance. Committed demand would improve utilization, reduce selling costs and potentially support customer advances, lifting earnings visibility and the valuation premium. A representative 35% probability reflects unresolved procurement selection and appropriations; the existing production-support award is not such an order. |
| Civilian endurance fleet enters service | 25% | +65% | An endurance-aviation customer moves from development flights into commercial fleet service during 2028–2030 and places a substantial production order. Recurring replacement-cell demand would diversify earnings beyond tactical drones and validate premium applications. A representative 25% probability recognizes uncertain customer financing, certification and lifecycle economics; headline specific energy alone cannot establish commercially viable fleet deployment. |
Company Financial AnalysisAmprius Technologies: Earnings and Financials Analysis by AI
Financial figures available as of Nov 16, 2026. Only filings and source records available by this analysis date are included. View latest Amprius Technologies financials here.
Earnings and financials
Amprius's November Q3 2026 release reports record revenue of $39.1 million, driven by SiCore drone demand and greater North American adoption. Losses narrowed, but research, commercialization and supplier-enablement spending still absorb much of the extra gross profit. The business is selling products at scale, not merely demonstrating laboratory technology. The September Form 10-Q nevertheless reports $48.0 million of operating cash outflow for the first nine months of 2026. That includes the nonrecurring Brighton exit payment alongside working-capital demands, so extrapolating the full outflow overstates recurring burn. Receivables and supplier advances still make the cash recovery less convincing than the sales recovery.
Revenue, earnings, and cash flow
The table compares up to five fiscal years of revenue, net income, and free cash flow available to this analysis.
| Fiscal year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | USD 73M | USD -44M | USD -35.5M |
| 2024 | USD 24.2M | USD -44.7M | USD -36.6M |
| 2023 | USD 8.8M | USD -36.8M | USD -43.1M |
| 2022 | USD 4.4M | USD -17.3M | USD -15.4M |
| 2021 | USD 2.8M | USD -9.9M | USD -8.6M |
Valuation context: historical P/E
The table compares up to five fiscal years of point-in-time valuation evidence available to this analysis.
| Fiscal year | P/E | Earnings basis | Currency basis | Ticker / reporting |
|---|---|---|---|---|
| 2025 | -- | TTM | Loss-making | USD / USD |
| 2024 | -- | TTM | Loss-making | USD / USD |
| 2023 | -- | TTM | Loss-making | USD / USD |
| 2022 | -- | Annual | Loss-making | USD / USD |
| 2021 | -- | Annual | Unavailable | USD / USD |
P/E uses historical market capitalization and earnings known at each period. Cross-currency observations are normalized to USD using point-in-time FX rates.
Profitability and margins
Amprius's November Q3 2026 release places gross margin near 27%, a substantial recovery from the earlier loss-making production model. SiCore volume and outsourced manufacturing underpin genuine progress, but cylindrical-cell mix and urgent freight prevented another clean sequential improvement. Customer-level pricing and production-yield disclosure remain limited. The earnings call also describes moving Fremont costs from cost of sales into research expense, improving gross margin without improving operating profit. Separately, management's annual adjusted EBITDA outlook includes $8 million of government income. The result is stronger unit economics, but not proof of unsubsidized profitability. Ocean freight offers savings; higher domestic labor and qualification costs could consume part of them.
The table compares up to five fiscal years of operating income and reported profitability margins.
| Fiscal year | Operating income | Operating margin | Net margin |
|---|---|---|---|
| 2025 | USD -46.6M | -63.9% | -60.3% |
| 2024 | USD -44.4M | -183.7% | -184.8% |
| 2023 | USD -38.7M | -440.3% | -418.3% |
| 2022 | USD -18M | -409.2% | -393.1% |
| 2021 | USD -10.6M | -383.2% | -357.0% |
Balance sheet and leverage
The September 2026 Form 10-Q reports $60.7 million of cash and no funded financial debt. That removes immediate borrowing and covenant pressure, but does not make the balance sheet self-replenishing. Receivables, inventory, supplier deposits and remaining lease commitments compete with domestic qualification for available cash. The production award is also not a cash reserve. The September agreement initially obligated approximately $22.3 million, with further support tied to funding and accepted milestones. An exhausted ATM program does not eliminate equity-raising capacity under the filed shelf. Dilution is a credible financing outcome, not a certainty; collections and grant timing determine how much additional ownership must be issued.
The table compares up to five fiscal years of debt, liquidity, net cash or debt, and current-ratio evidence.
| Fiscal year | Total debt | Cash + short-term investments | Reported net cash / (debt) | Debt less (cash + short-term investments), calculated | Current ratio |
|---|---|---|---|---|---|
| 2025 | USD 39.9M | USD 90.5M | USD 50.6M net cash | USD -50.6M | 7.08x |
| 2024 | USD 37.8M | USD 55.2M | USD 17.4M net cash | USD -17.4M | 4.00x |
| 2023 | USD 35.6M | USD 45.8M | USD 10.2M net cash | USD -10.2M | 3.75x |
| 2022 | USD 3M | USD 69.7M | USD 66.7M net cash | USD -66.7M | 10.87x |
| 2021 | USD -11.5M | USD 11.5M | USD 11.5M net cash | USD -23M | 3.40x |
Reported net debt retains the source definition, which can deduct cash alone. Cash plus short-term investments is broader liquidity; the separately calculated column subtracts that full amount from total debt for the same fiscal period and currency. Reported net debt below zero is displayed as net cash. Current ratio is current assets divided by current liabilities.
Capex and investment intensity
The FY2025 Form 10-K and subsequent filings describe a $20 million early-2026 payment to exit the Brighton factory lease. Management's November outlook keeps company capital expenditure below $10 million for 2026. This is a strategic change from building factories to developing cells and qualifying production partners, sharply reducing fixed commitments. The investment burden has moved, not vanished. Fremont development, engineering transfers, supplier advances and customer credit still require cash. The federally supported domestic retrofit includes partner and in-kind contributions; its full project cost is not an equivalent Amprius cash obligation. Installed partner capacity improves returns only when qualified cells ship, customers pay and utilization covers tolling costs.
The table compares up to five fiscal years of capital expenditure and research-and-development investment.
| Fiscal year | Capital expenditure | R&D spend |
|---|---|---|
| 2025 | USD 4.4M | USD 9.4M |
| 2024 | USD 3.2M | USD 7.3M |
| 2023 | USD 17.6M | USD 3.7M |
| 2022 | USD 1.5M | USD 2M |
| 2021 | USD 609K | USD 1.5M |
Behind the synthesisAmprius Technologies: How Each Individual AI Forecaster Opinion Shapes the Global Consensus
This publication’s recorded synthesis allocated voting influence across 11 advisor opinions. The weights and rationales below are retained from that synthesis.
The strongest supported pattern is rapid commercialization alongside working-capital absorption, grounded in quarterly reporting, filings and production agreements. These documents are repeatedly recycled, so agreement is not independent validation. Greater weight goes to reconciled earnings-based paths separating government support, partner capacity and customer orders. The strongest bullish challenge is that the lease-exit payment is nonrecurring and outsourced production can scale without another factory build. That survives scrutiny, but does not establish prompt cash breakeven. Conversely, deterministic dilution and automatic industrial-multiple convergence are assumptions, not disclosed outcomes. Unreconciled terminal arithmetic, unsupported market-share claims and extrapolation of headline energy density into robotics receive less influence. Domestic qualification, grant-excluded cash conversion and supplier bargaining remain decisive uncertainties. Factor earnings impacts represent sensitivities to modeled positive earnings, not growth rates from current losses.
Individual targets retain their original dates. Returns and ratings use the same latest available market close and dividend assumptions as the Consensus.
All 11 opinions
Consensus weight Allocation: 23.0/100. Weight Allocation Rationale: Detailed links to filings, contracts and product disclosures support the distinction between product qualification and control of manufacturing. Its terminal earnings bridge is internally coherent, and it correctly separates milestone support from customer orders. The relatively high weight reflects evidentiary discipline, not independent confirmation of shared company disclosures.
The 1-year target is $7.56 for , with +30.96% expected return and a STRONG BUY rating. The 5-year target is $11.19 for , with +94.02% expected return and a STRONG BUY rating.
Consensus weight Allocation: 22.0/100. Weight Allocation Rationale: Filings and the earnings call support its separation of recurring operations, government income and accounting reclassification. The earnings-based valuation bridge reconciles, and robotics remains optional rather than necessary. The high relative weight reflects a coherent causal chain; supplier economics, domestic yields and terminal margins still require substantial judgment.
The 1-year target is $7.79 for , with +34.95% expected return and a STRONG BUY rating. The 5-year target is $11.06 for , with +91.67% expected return and a STRONG BUY rating.
Consensus weight Allocation: 10.0/100. Weight Allocation Rationale: The owner-earnings bridge is internally coherent, and working-capital absorption provides a credible explanation for disappointing shareholder economics despite growth. However, dilution timing and terminal multiple compression remain assumptions. Repeated company disclosures provide limited independent confirmation, while older trailing valuation metrics overstate the current commercialization hurdle.
The 1-year target is $5.87 for , with +1.66% expected return and a PARTIAL SELL rating. The 5-year target is $7.56 for , with +30.99% expected return and a NEUTRAL rating.
Consensus weight Allocation: 9.0/100. Weight Allocation Rationale: The connection between defense localization, discount rates and financing requirements is economically consistent, and the path recognizes startup friction. However, macro claims repeat the same unverified inputs, while a specific equity raise and later cash-flow margins remain modeled assumptions. Moderate weight preserves the balanced mechanism without treating duplication as confirmation.
The 1-year target is $7.42 for , with +28.54% expected return and a STRONG BUY rating. The 5-year target is $11.09 for , with +92.18% expected return and a STRONG BUY rating.
Consensus weight Allocation: 9.0/100. Weight Allocation Rationale: The distinction between grant-supported adjusted earnings and recurring cash generation is material, supported by supplied company reporting. Working-capital and supplier dependencies are also well identified. Weight is restrained because terminal commercialization benefits rely on less-supported product assumptions, and relocating production does not automatically remove upstream materials dependence.
The 1-year target is $7.96 for , with +38.04% expected return and a STRONG BUY rating. The 5-year target is $14.46 for , with +150.55% expected return and a STRONG BUY rating.
Consensus weight Allocation: 8.0/100. Weight Allocation Rationale: Primary filings support the financing bridge and the difference between compliance and a secured franchise. The lower-growth case is plausible and preserves competition risk. Weight is moderated because recurring burn, financing size and timing are not firmly established, while sales-based terminal valuation leaves profitability capture less explicitly reconciled.
The 1-year target is $7.47 for , with +29.41% expected return and a STRONG BUY rating. The 5-year target is $9.86 for , with +70.93% expected return and a BUY rating.
Consensus weight Allocation: 5.0/100. Weight Allocation Rationale: The manufacturing pivot and standard-equipment compatibility provide a credible bullish counterweight to persistent-burn extrapolation. However, rapid margin expansion, full localization benefits and large robotics adoption are assumed more readily than demonstrated. Shared company sources and speculative adjacency claims limit how much influence its optimistic complete path deserves.
The 1-year target is $8.85 for , with +53.37% expected return and a STRONG BUY rating. The 5-year target is $16.71 for , with +189.54% expected return and a STRONG BUY rating.
Consensus weight Allocation: 5.0/100. Weight Allocation Rationale: Incremental funding and sourcing eligibility are important, lasting constraints supported by the award structure. The report usefully treats policy as both opportunity and execution risk. Unverified market-share and insider-flow claims, uncertain legal interpretations and overstatement of company project contributions reduce confidence in its specific political and numerical path.
The 1-year target is $7.00 for , with +21.35% expected return and a STRONG BUY rating. The 5-year target is $11.35 for , with +96.70% expected return and a STRONG BUY rating.
Consensus weight Allocation: 4.0/100. Weight Allocation Rationale: Receivables, conditional grant funding and onshoring costs form a credible downside chain, but the stated terminal revenue, EBITDA margin and valuation multiple do not reconcile with terminal enterprise value. That material internal inconsistency reduces the path's weight; unsupported interpretations of insider sales add little independent evidence.
The 1-year target is $5.07 for , with -12.10% expected return and a SELL ALL rating. The 5-year target is $9.62 for , with +66.74% expected return and a BUY rating.
Consensus weight Allocation: 3.0/100. Weight Allocation Rationale: The nonrecurring lease exit is a useful challenge to mechanical cash-burn extrapolation, and outsourced growth can improve economics. However, no source receipts accompany several positioning and profitability claims, and early self-funding is asserted rather than established. Its distinctive normalization insight survives, but the numerical path receives limited weight.
The 1-year target is $9.39 for , with +62.67% expected return and a STRONG BUY rating. The 5-year target is $17.55 for , with +204.17% expected return and a STRONG BUY rating.
Consensus weight Allocation: 2.0/100. Weight Allocation Rationale: The warning that technological success need not create owner value is sound. Its adverse path, however, underincorporates already reported margins and awarded domestic support, with upside thresholds below current reported performance. Limited source documentation and categorical multiple-compression claims make this a small retained valuation stress perspective.
The 1-year target is $6.78 for , with +17.43% expected return and a STRONG BUY rating. The 5-year target is $5.76 for , with -0.15% expected return and a PARTIAL SELL rating.
References & Context
Research Provenance
Analysis generated by iPulse AI Engine v9 using recorded market data, operating under the editorial standards and supervision of Russlan Ramdowar, Editor-in-Chief.
External references below are sources recorded by the researcher agents for this Amprius Technologies forecast batch.
Primary analysis inputs
- iPulse AI Multi-Agent Forecasts — independent analyst personas, model outputs, and consensus synthesis.
- iPulse AI Global Events Context — macroeconomic, geopolitical, regulatory, and industry-event context.
- Structured market history — prices, distributions, volatility, identifiers, and listing metadata.
- Company earnings and financial statements — revenue, profitability, balance-sheet, cash-flow, and investment trends.
- Researcher web evidence — public sources consulted to challenge and contextualize the forecast thesis.
Sources retained from AI Researcher searches
Asset-specific · Researcher web40 available sources from this batch (97 recorded). The first 15 are shown below; expand to read the rest.
Some model providers retained only the consulted domain, not an exact article URL. Those domains are shown as evidence without inventing a link.
- sec.gov sec.gov
- Amprius Technologies, Inc. - Form 10-Q - FY2026 sec.gov
- Amprius Technologies, Inc. - Form 10-Q - FY2026 sec.gov
- Amprius Technologies, Inc. - Form 8-K - FY2026 sec.gov
- Amprius Technologies, Inc. - Form 8-K - FY2026 sec.gov
- www.sec.gov sec.gov
- amprius.com amprius.com
- stocktitan.net stocktitan.net
- investing.com investing.com
- seekingalpha.com seekingalpha.com
- tradingview.com tradingview.com
- biggo.com biggo.com
- marketbeat.com marketbeat.com
- cloudfront.net cloudfront.net
- fool.com fool.com
Show 25 more sources
- perplexity.ai perplexity.ai
- stockanalysis.com stockanalysis.com
- koalagains.com koalagains.com
- meticulousresearch.com meticulousresearch.com
- nasdaq.com nasdaq.com
- reddit.com reddit.com
- youtube.com youtube.com
- battery-tech.net battery-tech.net
- businessquant.com businessquant.com
- caminuspower.com caminuspower.com
- AMPX Q3 2026 Earnings Call Transcript d1io3yog0oux5.cloudfront.net
- finsee.ai finsee.ai
- futuremarketinsights.com futuremarketinsights.com
- gurufocus.com gurufocus.com
- Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent Business Highlights :: Amprius Technologies, Inc. (AMPX) ir.amprius.com
- November 12, 2026 - 10-Q: Quarterly report [Sections 13 or 15(d)] | Amprius Technologies, Inc. (AMPX) ir.amprius.com
- September 28, 2026 - 8-K: Current report | Amprius Technologies, Inc. (AMPX) ir.amprius.com
- kalkinemedia.com kalkinemedia.com
- minichart.com.sg minichart.com.sg
- newsfilter.io newsfilter.io
- pulse2.com pulse2.com
- quantisnow.com quantisnow.com
- quartr.com quartr.com
- substack.com substack.com
- tac-nrg.com tac-nrg.com
57 additional sources are recorded in this batch; their citation details are not available in this publication.
Context retained with this Consensus
The same public-safe market, global-event, and fundamental context supplied to the AI Advisor panel.
Global context snapshot
2026 Year-to-Date Global Market and World-Events Context Through November 14
Download Archived SnapshotCoverage 2026-01-01 to 2026-11-14 · Knowledge cutoff 2026-11-14
January 1-November 14, 2026: persistent inflation, partial oil supply recovery, US midterms and trade, AI financing, and uneven growth.
Archived context covering 2026-01-01 to 2026-11-14. Its recorded scope includes monetary policy and rates; geopolitics energy and shipping; trade and industrial policy. Selected highlights reflect the analysis cutoff, not current world conditions.
Show moreShow less
- File size
- 96K bytes
- Words
- 14.2K words
- Characters
- 96K characters
- Est. tokens (characters ÷ 4)
- 24K tokens
Fed held at 3.75%-4.00%; Democrats won the next Congress, Nvidia changed leadership and Anthropic filed preliminary IPO terms. Markets through November 13.
| Selected highlights from this archived snapshot | Date | Status |
|---|---|---|
| Renewed monetary tightening amid persistent inflation | 2026-01-30 | ACTIVE POLICY REGIME |
| Iran/Hormuz conflict and wider energy-security disruption | 2026-02-28 | ONGOING |
| US tariff reset, trade truce and incoming divided government | 2026-02-20 | ACTIVE POLICY REGIME |
Representative Sources of the Context File
And more sources from the retained context package.
Fundamental Context Passed as Input to the Models
Time range: Annual fiscal periods: 2020-12-31–2025-12-31, 6 periods; Quarterly fiscal periods: 2023-12-31–2026-06-30, 11 periods.
Currencies cited: USD (quote USD; primary reporting USD; converted/valuation USD).
Show moreShow less
Income statement
9 fieldsdepreciationAndAmortization · ebit · ebitda · grossProfit · +5 more fields
Balance sheet
10 fieldscash · commonStockSharesOutstanding · netDebt · netReceivables · +6 more fields
Cash flow
4 fieldscapitalExpenditures · freeCashFlow · salePurchaseOfStock · totalCashFromOperatingActivities
End of the paywalled preview
The excerpt from Deep Dive: detailed analysis to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.
Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.
Additional with full access
Individual AI Advisor reports
- Investment theses
- Bull and bear scenarios and alpha signals
- Drivers, headwinds, risks and opportunities
- Quarterly forecast rationale
- Advisor research references and configuration
Additional datasets and interactive tools
- Interactive forecast comparisons
- Available detailed financial statements
- Market history and corporate-action adjustments
- Eligible historical publication workspaces
Explore complete public research examples
These public assets show the complete AI Consensus research. Their findings concern those assets, not this report.
Amprius Technologies: forecast questions
What is Amprius Technologies (AMPX)'s 1-year price forecast?
Amprius Technologies's 1-year target is $7.41 for Nov 2027. The current AI rating is STRONG BUY. The expected return from the recorded close is +28.42%, or +28.42% modeled return including net dividends. Latest available market price: USD 5.77, as of 20 Nov 2026. The target date is fixed at publication.
What is Amprius Technologies (AMPX)'s 5-year price forecast?
Amprius Technologies's 5-year target is $11.20 for Nov 2031. The current AI rating is STRONG BUY. The expected return from the recorded close is +94.11%, or +94.11% modeled return including net dividends. Latest available market price: USD 5.77, as of 20 Nov 2026. The target date is fixed at publication.
How can I compare the AI opinions and audit past Amprius Technologies forecasts?
11 AI analysts contribute to this publication. AI Opinions shows individual advisor forecasts and reasoning. Forecast History lists the available batches with their original publication dates.
How does an AI-generated forecast for Amprius Technologies differ from Wall Street analyst consensus?
Wall Street consensus aggregates estimates from human analysts. For listed companies, these typically include brokerage price targets, earnings forecasts and ratings. iPulse AI's forecast for Amprius Technologies is a separate AI consensus generated through its own research workflow. Different inputs, forecast dates, assumptions and weighting can therefore produce different targets.
We believe the era of investment research conducted only by human analysts is drawing to a close. Frontier models increasingly match or exceed expert work on selected professional benchmarks, including evaluations covering financial analysis. Research on multi-model synthesis also shows that combining model responses can improve on a single model's output in the tasks studied.
iPulse AI generates transparent investment research and market forecasts using a swarm of AI configurations, analytical frameworks and frontier models. The workflow applies multiple verification, challenge and synthesis layers, with selective editorial review under Russlan Ramdowar, Editor-in-Chief. Published assumptions, disagreements and past forecasts remain available so readers can inspect the reasoning and audit outcomes.
For a research cycle covering 426 assets with 14 perspectives per asset, our internal workload model estimates approximately 114,000 hours of traditional analyst work. It assumes 16 hours per individual research report, 28 hours per consensus for synthesis and validation, plus shared data preparation. Parallel AI execution allows a deep-analysis cycle across hundreds of assets to complete in up to one day. The human-hours figure is an illustrative workload estimate, rather than measured time savings. Our research methodology explains the automated workflow.
If iPulse AI produces thousands of investment reports - work estimated to require over 100,000 traditional analyst hours - isn't that just "AI slop" at scale?
No. iPulse AI produces AI-generated research at scale, but the purpose is depth of analysis, comparison, and accountability. The number of reports is a consequence of the research process; it is not the goal.
iPulse AI does not produce thin copies of existing websites, articles, or investment reports. We use frontier models as an Analytical Intelligence layer. Our Financial Experts select, validate, curate, and supply the input data, including proprietary inputs, so the models work from a prepared evidence base.
In Researcher mode, models can also search the web to check current information, test assumptions, and investigate evidence that may be missing from the supplied data. This can include lobbying expenditure, management developments, regulatory decisions, or other facts relevant to a particular investment thesis. Thinker mode focuses on deep reasoning over the supplied data and context.
Our process goes much further than asking ChatGPT to evaluate a stock. Our team designs structured investment frameworks inspired by the approaches of influential investors, economists, political thinkers, and technological visionaries. These are AI analytical frameworks, not reports written or endorsed by the people who inspired them.
Each asset is analyzed separately through multiple frameworks and configurations, using specialized inputs and task instructions. Different perspectives examine different questions: valuation, business quality, technological disruption, macroeconomic conditions, political influence, financial risks, and more.
Cloud infrastructure allows these workflows to run at scale. That scale also comes with quality assurance at scale: up to 30% of report-generation attempts fail our QA checks. We rerun failed attempts until a clean report passes those checks. Users are presented only with reports that have passed QA.
This explains the volume. The value comes from what we do with the analysis.
A second layer synthesizes the individual reports into an asset-level consensus. This is where we recommend starting when researching a particular asset: it brings together the central thesis, supporting evidence, risks, and disagreements while preserving access to the underlying opinions.
We then compare assets through our proprietary iPulse AI Consensus Score, whose methodology is publicly explained. This helps users move from understanding one asset to comparing opportunities across the analyzed universe.
A further research and editorial layer examines leading candidates, checks current evidence, and develops focused Editorial Top Picks across broad-market and dedicated asset categories. Human editors review the evidence and approve each published edition. For example, explore our Best Long-Term Investments.
But the process does not end when a report is published. We preserve past forecasts so users with the relevant subscription can inspect what the system actually said and compare it with subsequent market outcomes. As more forecasts reach their target dates, the historical record becomes more useful for evaluating which approaches worked, which failed, and under what conditions.
We publish research on our website, arXiv, and Zenodo, alongside explanatory writing on Medium. We use the evidence to refine our data, frameworks, validation, and workflows, and document important findings in Lessons Learned.
The standard we ask users to judge us by is the reasoning, evidence, and historical record behind the research.
How does the iPulse AI Engine work?
The engine runs AI advisor configurations against a shared set of research inputs. The engine history explains the research workflow and what changed between versions.








